Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Patents: Active

AKEBIA THERAPEUTICS, INC. Active Patents

33 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-12-12: Application 18537481; Invention PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE; Applicant Akebia Therapeutics, Inc.; Status Patented Case.
  • 2023-11-16: Application 18511042; Invention COMPOSITIONS AND METHODS FOR TREATING ANEMIA; Applicant Akebia Therapeutics, Inc.; Status Patented Case.
  • 2023-06-29: Application 18259897; Invention THERAPEUTIC METHODS USING VADADUSTAT; Applicant Akebia Therapeutics, Inc.; Status Patented Case.
  • 2023-06-13: Application 18334101; Invention Process for Preparing 2-[[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino]Acetic Acid; Applicant Akebia Therapeutics, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-12-1218537481PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USEAkebia Therapeutics, Inc.Patented Case2025-11-2512478615US20240358691A1
Richard Masaru Kawamoto
Shengde Wu
Artem G. Evdokimov
Kenneth D. Greis
Angelique Sun Boyer
Namal C. Warshakoon
United States
United States
United States
United States
United States
United States
CARCANAGUE, DANIEL R
2023-11-1618511042COMPOSITIONS AND METHODS FOR TREATING ANEMIAAkebia Therapeutics, Inc.Patented Case2026-03-1012569474US20240335434A1
Robert Shalwitz
Charlotte Hartman
Akshay Buch
Isaiah Shalwitz
John Janusz
Joseph Gardner
United States
United States
United States
United States
United States
United States
WHEELER, THURMAN MICHAEL
2023-06-2918259897THERAPEUTIC METHODS USING VADADUSTATAkebia Therapeutics, Inc.Patented Case2026-08-0412697330US20240325360A1
Steven BURKE
Ajit CHAVAN
Zeeshan KHAWAJA
United States
United States
United States
PATEL, SAGAR S
2023-06-1318334101Process for Preparing 2-[[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino]Acetic AcidAkebia Therapeutics, Inc.Patented Case2025-04-0812269802US20240158354A1
Boris I. Gorin
Christopher M. Lanthier
Anne Buu Chau Luong
James Densmore Copp
Javier Gonzalez
Sascha Jautze
Erich Kraus
Alan O'Connor
Canada
Canada
Canada
United States
United States
United States
Germany
United States
RAHMANI, NILOOFAR
2023-05-1718319287SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Patented Case2025-09-2312419877US20240122910A1
James Densmore Copp
Ann W. Newman
Anne Luong
United States
United States
Canada
AULAKH, CHARANJIT
2022-12-2317783816METHOD FOR PRODUCING NITROGEN-CONTAINING HETEROARYLCARBOXAMIDE ACETIC ACID DERIVATIVEAkebia Therapeutics, Inc.Patented Case2026-04-2812612367US20230159462A1
Kazufumi OOTSUKI
Muneki KISHIDA
Atsushi MORODA
Kohki FUKUHARA
Hirotoshi YAGISHITA
Japan
Japan
Japan
Japan
Japan
SEAMAN, D MARGARET M
2022-10-1917996575TREATMENT OF VIRAL INFECTIONS, OF ORGAN INJURY, AND OF RELATED CONDITIONS USING A HIF PROLYL HYDROXYLASE INHIBITOR OR A HIF-ALPHA STABILIZERAkebia Therapeutics, Inc.Patented Case2026-05-1912629357US20230218592A1
Steven BURKE
Michael RABINOWITZ
United States
United States
GAUGER, PAUL RANDALL
2022-09-1917906653PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND THEIR USEAkebia Therapeutics, Inc.Patented Case2026-08-1112703691US20230212138A1
Paul E. FLEMING
Thomas P. BLAISDELL
Senkara Rao ALLU
United States
United States
United States
PECKHAM, RICHARD GRANT
2022-07-2717815391PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USEAkebia Therapeutics, Inc.Patented Case2024-01-3011883386US20230201178A1
Richard Masaru Kawamoto
Shengde Wu
Artem G. Evdokimov
Kenneth D. Greis
Angelique Sun Boyer
Namal C. Warshakoon
United States
United States
United States
United States
United States
United States
CARCANAGUE, DANIEL R
2022-04-0417712709Compositions and Methods for Treating AnemiaAkebia Therapeutics, Inc.Patented Case2023-12-1911844756US20230071553A1
Alexander Smith
Gurudatt Ajay Chandorkar
Ene Ikpong Ette
Bradley John Maroni
Charlotte Suzanne Hartman
Ramin Farzaneh-Far
Jula Kern Inrig
United States
United States
United States
United States
United States
United States
United States
HARTSFIELD, KATHRIEN ANN
2022-01-3117589118PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDESAkebia Therapeutics, Inc.Patented Case2026-07-0712673919US20230002323A1
Christopher M. Lanthier
Boris Gorin
Jan Oudenes
Craig Edward Dixon
Alan Quigbo Lu
James Densmore Copp
John Michael Janusz
Canada
Canada
Canada
Canada
Canada
United States
United States
SEAMAN, D MARGARET M
2021-06-1517347700SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Patented Case2023-07-0411690836US20220040159A1
James Densmore Copp
Ann W. Newman
Anne Luong
United States
United States
Canada
AULAKH, CHARANJIT
2020-11-1217095998SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACIDAkebia Therapeutics, Inc.Patented Case2022-12-1311524939US20210206721A1
Sudhir Ranjan
Xiaoyang Wang
United States
China
SHAMEEM, GOLAM M
2020-11-0617053614Process for Preparing 2-[[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-Carbonyl]Amino]Acetic AcidAkebia Therapeutics, Inc.Patented Case2023-08-0111713298US20210070709A1
Boris I. Gorin
Christopher M. Lanthier
Anne Buu Chau Luong
James Densmore Copp
Javier Gonzalez
Sascha Jautze
Erich Kraus
Alan O'Connor
Canada
Canada
Canada
United States
United States
United States
Germany
United States
RAHMANI, NILOOFAR
2020-07-0616921273PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDESAkebia Therapeutics, Inc.Patented Case2022-03-0811267785US20210122715A1
Christopher M. Lanthier
Boris Gorin
Jan Oudenes
Craig Edward Dixon
Alan Quigbo Lu
James Densmore Copp
John Michael Janusz
Canada
Canada
Canada
Canada
Canada
United States
United States
MORRIS, PATRICIA L
2020-06-2216908092PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USEAkebia Therapeutics, Inc.Patented Case2022-08-3011426393US20210137901A1
Richard Masaru Kawamoto
Shengde Wu
Artem G. Evdokimov
Kenneth D. Greis
Angelique Sun Boyer
Namal C. Warshakoon
United States
United States
United States
United States
United States
United States
CARCANAGUE, DANIEL R
2020-02-1016786187SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Patented Case2021-07-2011065237US20200345711A1
James Densmore Copp
Ann W. Newman
Anne Luong
United States
United States
Canada
AULAKH, CHARANJIT
2019-03-1316352705PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDESAkebia Therapeutics, Inc.Patented Case2020-08-1110738010US20190375713A1
Christopher M. Lanthier
Boris Gorin
Jan Oudenes
Craig Edward Dixon
Alan Quigbo Lu
James Densmore Copp
John Michael Janusz
Canada
Canada
Canada
Canada
Canada
United States
United States
MORRIS, PATRICIA L
2018-11-0116178191SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Patented Case2020-03-2410596158US20190290624A1
James Densmore Copp
Ann W. Newman
Anne Luong
United States
United States
Canada
AULAKH, CHARANJIT
2018-08-3116119146PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USEAkebia Therapeutics, Inc.Patented Case2020-08-0410729681US20190192494A1
Richard Masaru Kawamoto
Shengde Wu
Artem G. Evdokimov
Kenneth D. Greis
Angelique Sun Boyer
Namal C. Warshakoon
United States
United States
United States
United States
United States
United States
CARCANAGUE, DANIEL R
2018-05-3115994348SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Patented Case2018-12-1110149842US20180280365A1
James Densmore Copp
Ann W. Newman
Anne Luong
United States
United States
Canada
AULAKH, CHARANJIT
2018-01-1915875495PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USEAkebia Therapeutics, Inc.Patented Case2019-06-18RE47437
Richard Masaru Kawamoto
Shengde Wu
Artem G. Evdokimov
Kenneth D. Greis
Angelique Sun Boyer
Namal C. Warshakoon
United States
United States
United States
United States
United States
United States
CAMPELL, BRUCE R
2017-09-2915563169Compositions and Methods for Treating AnemiaAkebia Therapeutics, Inc.Patented Case2022-05-1011324734US20180092892A1
Alexander Smith
Gurudatt Ajay Chandorkar
Ene Ikpong Ette
Bradley John Maroni
Charlotte Suzanne Hartman
Ramin Farzaneh-Far
Jula Kem Inrig
United States
United States
United States
United States
United States
United States
United States
HARTSFIELD, KATHRIEN ANN
2017-08-3115692255PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDESAkebia Therapeutics, Inc.Patented Case2019-04-0210246416US20170362178A1
Christopher M. Lanthier
Boris Gorin
Jan Oudenes
Craig Edward Dixon
Alan Quigbo Lu
James Denmore Copp
John Michael Janusz
Canada
Canada
Canada
Canada
Canada
United States
United States
MORRIS, PATRICIA L
2017-05-3015608186SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Patented Case2018-06-059987262US20170258773A1
James Densmore Copp
Ann W. Newman
Anne Luong
United States
United States
Canada
AULAKH, CHARANJIT
2016-01-2215004034SOLID FORMS OF 2-(5-(3-FLUOROPHENYL)-3-HYDROXYPICOLINAMIDO)ACETIC ACID, COMPOSITIONS, AND USES THEREOFAKEBIA THERAPEUTICS, INC.Patented Case2018-12-1110150734US20160214939A1
ROGER HANSELMANN
ANNE LUONG
United States
Canada
HEYER, DENNIS
2015-12-1114897849COMPOSITIONS AND METHODS FOR TREATING ANEMIAAKEBIA THERAPEUTICS, INC.Patented Case2024-01-0211857543US20160143891A1
Robert Shalwitz
Charlotte Hartman
Akshay Buch
Isaiah Shalwitz
John Janusz
Joseph Gardner
United States
United States
United States
United States
United States
United States
WHEELER, THURMAN MICHAEL
2015-09-1514854080PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USEAkebia Therapeutics, Inc.Patented Case2017-03-219598370US20160009648A1
Richard Masaru Kawamoto
Shengde Wu
Artem G. Evdokimov
Kenneth D. Greis
Angelique Sun Boyer
Namal C. Warshakoon
United States
United States
United States
United States
United States
United States
CARCANAGUE, DANIEL R
2015-08-2414833222PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDESAkebia Therapeutics, Inc.Patented Case2017-10-039776969US20150361043A1
Christopher M. Lanthier
Boris Gorin
Jan Oudenes
Craig Edward Dixon
Alan Quigbo Lu
James Densmore Copp
John Michael Janusz
Canada
Canada
Canada
Canada
Canada
United States
United States
MICHELSON, BEN S
2014-11-1414541284SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOFAkebia Therapeutics, Inc.Patented Case2017-07-119701636US20150141467A1
James Densmore Copp
Ann W. Newman
Anne Luong
United States
United States
Canada
MICHELSON, BEN S
2013-10-2414062011PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USEAkebia Therapeutics, Inc.Patented Case2015-01-278940773US20140045899A1
Richard Masaru Kawamoto
Shengde Wu
Artem G. Evdokimov
Kenneth D. Greis
Angelique Sun Boyer
Namal C. Warshakoon
United States
United States
United States
United States
United States
United States
CARCANAGUE, DANIEL R
2013-04-0913859574PROLYL HYDROXYLASE INHIBITORS AND METHOD OF USEAKEBIA THERAPEUTICS INC.Patented Case2014-05-138722895US20130245076A1
Richard Masaru Kawamoto
Shengde Wu
Artem G. Evdokimov
Kenneth D. Greis
Angelique Sun Boyer
Namal C. Warshakoon
United States
United States
United States
United States
United States
United States
CARCANAGUE, DANIEL R
2012-11-2013681876PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USEAkebia Therapeutics Inc.Patented Case2013-12-038598210US20130203816A1
Richard Masaru Kawamoto
Shengde Wu
Namal C. Warshakoon
Artem G. Evdokimov
Kenneth D. Greis
Angelique Sun Boyer
United States
United States
United States
United States
United States
United States
CARCANAGUE, DANIEL R

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33